Ocular and Stem Cell Translational Research Section, NEI, NIH, Bethesda, MD 20892, USA.
Centre for Ocular Regeneration, Prof. Brien Holden Eye Research Centre, Hyderabad Eye Research Foundation, LV Prasad Eye Institute, Hyderabad 500034, Telangana, India.
Stem Cell Reports. 2022 Nov 8;17(11):2438-2450. doi: 10.1016/j.stemcr.2022.10.001. Epub 2022 Oct 27.
Stargardt retinopathy is an inherited form of macular degeneration caused by mutations in gene ABCA4 and characterized by the accumulation of lipid-rich deposits in the retinal pigment epithelium (RPE), RPE atrophy, and photoreceptor cell death. Inadequate mechanistic insights into pathophysiological changes occurring in Stargardt RPE have hindered disease treatments. Here, we show that ABCA4 knockout and induced pluripotent stem cell-derived RPE (STGD1-iRPE) from patients with Stargardt differentiate normally but display intracellular lipid and ceramide deposits reminiscent of the disease phenotype. STGD1-iRPE also shows defective photoreceptor outer segment (POS) processing and reduced cathepsin B activity-indicating higher lysosomal pH. Lipid deposits in STGD1-iRPE are lowered by increasing the activity of ABCA1, a lipid transporter, and ABCA4 ortholog. Our work suggests that ABCA4 is involved in POS and lipid handling in RPE cells and provides guidance for ongoing gene therapy approaches to target both RPE and photoreceptor cells for an effective treatment.
斯塔加特氏视网膜病变是一种遗传性黄斑变性,由 ABCA4 基因突变引起,其特征是视网膜色素上皮(RPE)中富含脂质的沉积物积累、RPE 萎缩和光感受器细胞死亡。对斯塔加特氏 RPE 中发生的病理生理变化的机制认识不足,阻碍了疾病的治疗。在这里,我们表明 ABCA4 敲除和诱导多能干细胞衍生的 RPE(STGD1-iRPE)来自斯塔加特氏病患者,它们正常分化,但表现出类似于疾病表型的细胞内脂质和神经酰胺沉积。STGD1-iRPE 还显示出光感受器外节(POS)处理缺陷和组织蛋白酶 B 活性降低,表明溶酶体 pH 值升高。通过增加脂质转运蛋白 ABCA1 和 ABCA4 同源物的活性,可以降低 STGD1-iRPE 中的脂质沉积。我们的工作表明 ABCA4 参与 RPE 细胞中 POS 和脂质的处理,并为正在进行的基因治疗方法提供指导,以针对 RPE 和光感受器细胞进行有效治疗。